Biogen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,383	3,009	2,375	1,050	3,419	2,261
Short-Term Investments	1,366	807.2	-	-	1,474	1,541
Cash & Short-Term Investments	4,748	3,816	2,375	1,050	4,893	3,803
Cash Growth	82.75%	60.66%	126.21%	-78.54%	28.67%	45.68%
Accounts Receivable	1,369	1,342	1,405	1,664	1,705	1,549
Other Receivables	421.2	524.6	464	435.9	431.4	412.3
Total Trade Receivables	1,790	1,867	1,869	2,100	2,136	1,962
Inventory	1,949	2,168	2,461	2,527	1,344	1,352
Other Current Assets	1,168	1,123	752.5	1,182	1,418	740.8
Total Current Assets	9,190	8,974	7,457	6,859	9,791	7,857
Net Property, Plant & Equipment	251.3	265.4	356.4	420	403.9	375.4
Other Intangible Assets	9,054	9,179	9,691	8,363	1,850	2,221
Goodwill	6,489	6,491	6,479	6,219	5,749	5,761
Long-Term Investments	777.5	1,183	560.5	745	2,235	2,832
Other Long-Term Assets	238.2	292.5	324.2	928.6	1,226	1,415
Total Assets	29,483	29,440	28,049	26,845	24,554	23,877
Accounts Payable	358.5	432	424.2	403.3	491.5	589.2
Accrued Expenses	2,547	2,803	2,808	2,624	2,521	2,535
Current Portion of Long-Term Debt	-	-	1,749	150	-	999.1
Other Current Liabilities	93.6	114.8	548.3	257.4	259.9	174.7
Total Current Liabilities	2,999	3,349	5,529	3,434	3,273	4,298
Long-Term Debt	6,289	6,287	4,547	6,788	6,281	6,274
Long-Term Leases	273.4	290.4	334.5	400	333	330.4
Other Long-Term Liabilities	1,271	1,256	922.8	1,423	1,279	2,015
Total Long-Term Liabilities	7,833	7,833	5,805	8,611	7,893	8,619
Total Liabilities	10,831	11,183	11,333	12,045	11,166	12,918
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Treasury Stock	-2,977	-2,977	-2,977	-2,977	-2,977	-2,977
Additional Paid-in Capital	896.7	863.1	569.4	302.5	73.3	68.2
Accumulated Other Comprehensive Income	-140.2	-182	-136.2	-153.7	-164.9	-106.7
Retained Earnings	20,872	20,553	19,260	17,628	16,467	13,912
Total Common Shareholders' Equity	18,652	18,257	16,716	14,799	13,398	10,896
Minority Interest	-	-	-	-	-9.5	63.5
Shareholders' Equity	18,652	18,257	16,716	14,799	13,388	10,960
Total Liabilities & Equity	29,483	29,440	28,049	26,845	24,554	23,877
Total Debt	6,562	6,577	6,630	7,338	6,614	7,604
Net Cash (Debt)	-1,814	-2,762	-4,255	-6,288	-1,721	-3,801
Net Cash Per Share	-12.32	-18.77	-29.17	-43.19	-11.79	-25.41
Book Value	18,652	18,257	16,716	14,799	13,398	10,896
Book Value Per Share	126.69	124.11	114.57	101.64	91.77	72.84
Tangible Book Value	3,110	2,587	545.9	217.2	5,799	2,914
Tangible Book Value Per Share	21.12	17.59	3.74	1.49	39.72	19.48

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q